| Literature DB >> 33239687 |
Ming-Cheng Yu1, Feng Yang1,2, Xiao-Yu Ding3,2, Nan-Nan Sun1,4, Zheng-Yuan Jiang1, Ya-Fei Huang1, Yu-Rong Yan1, Chen Zhu1, Qiong Xie1,5, Zhi-Feng Chen3,2, Si-Qi Guo2, Hua-Liang Jiang3,2,6, Kai-Xian Chen3,2, Cheng Luo3,2,6, Xiao-Min Luo7,8, Shi-Jie Chen9,10, Yong-Hui Wang11.
Abstract
A series of 6-substituted carbazole-based retinoic acid-related orphan receptor gamma-t (RORγt) modulators were discovered through 6-position modification guided by insights from the crystallographic profiles of the "short" inverse agonist 6. With the increase in the size of the 6-position substituents, the "short" inverse agonist 6 first reversed its function to agonists and then to "long" inverse agonists. The cocrystal structures of RORγt complexed with the representative "short" inverse agonist 6 (PDB: 6LOB), the agonist 7d (PDB: 6LOA) and the "long" inverse agonist 7h (PDB: 6LO9) were revealed by X-ray analysis. However, minor differences were found in the binding modes of "short" inverse agonist 6 and "long" inverse agonist 7h. To further reveal the molecular mechanisms of different RORγt inverse agonists, we performed molecular dynamics simulations and found that "short" or "long" inverse agonists led to different behaviors of helixes H11, H11', and H12 of RORγt. The "short" inverse agonist 6 destabilizes H11' and dislocates H12, while the "long" inverse agonist 7h separates H11 and unwinds H12. The results indicate that the two types of inverse agonists may behave differently in downstream signaling, which may help identify novel inverse agonists with different regulatory mechanisms.Entities:
Keywords: MD simulation; RORγt; agonists; cocrystal structures; “long” inverse agonists; “short” inverse agonists
Mesh:
Substances:
Year: 2020 PMID: 33239687 PMCID: PMC8379218 DOI: 10.1038/s41401-020-00552-w
Source DB: PubMed Journal: Acta Pharmacol Sin ISSN: 1671-4083 Impact factor: 7.169